A detailed history of Qube Research & Technologies LTD transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 8,947 shares of PDSB stock, worth $29,435. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,947
Holding current value
$29,435
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.55 - $4.02 $22,814 - $35,966
8,947 New
8,947 $26,000
Q1 2023

May 15, 2023

BUY
$5.68 - $11.99 $1.14 Million - $2.41 Million
201,083 New
201,083 $1.24 Million
Q2 2022

Aug 15, 2022

SELL
$3.05 - $6.68 $42,279 - $92,598
-13,862 Closed
0 $0
Q1 2022

May 09, 2022

SELL
$4.78 - $8.43 $98,855 - $174,340
-20,681 Reduced 59.87%
13,862 $86,000
Q4 2021

Feb 01, 2022

BUY
$7.76 - $14.35 $268,053 - $495,692
34,543 New
34,543 $280,000

Others Institutions Holding PDSB

About PDS Biotechnology Corp


  • Ticker PDSB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,458,700
  • Market Cap $93.6M
  • Description
  • PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...
More about PDSB
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.